Navigation Links
Colorectal cancer survival advantage in MUTYH-associated polyposis
Date:11/2/2010

Survival for colorectal cancer patients with MUTYH-associated polyposis was statistically significantly better than for patients with colorectal cancer from the general population, according to a recent study published online November 2 in The Journal of the National Cancer Institute.

People who inherit a mutation in the MUTYH gene have nearly a 100% risk for developing colon cancer at some point in their lifetimes. But it is unknown whether specific histological and molecular genetic features of cancer associated with this genotype influence tumor behavior and survival.

To determine whether patients with MUTYH-associated polyposis colorectal cancer had different survival rates than control colorectal cancer patients, Maartje Nielsen, M.D., of the Leiden University Medical Center, and colleagues, conducted a multicenter cohort study in Europe that included 147 patients with MUTYH-associated polyposis colorectal cancer and 272 population-based control patients with colorectal cancer. Control and study group patients were matched for country, stage, age and year at diagnosis, and cancer subsite.

The researchers found that survival of patients with MUTYH-associated polyposis colorectal cancer was statistically significantly better than for control patients with colorectal cancer. Their five-year survival rate was 78% compared with 63% for the control group. Survival benefit was higher among patients with stage I and II disease than for those with stage III and IV disease.

The researchers offer a speculation about the better survival rate among the patients with MUTYH-associated polyposis colorectal cancer, compared with the control patients: "A compromised base excision repair system could render MUTYH-associated polyposis colorectal cancer more immunogenic than sporadic colorectal cancers, which are characterized predominantly by chromosomal instability."

In an accompanying editorial, Henry T. Lynch, MD, and Stephen J. Lanspa, MD, of Creighton University, hypothesize that the cancer-causing mutations in MUTYH, as well as in the mismatch repair genes predisposing to Lynch syndrome, are the causal factors for their respective survival advantages. Furthermore, they write, "the ultimate understanding of the pathogenetic pathways elicited by these respective mutations may serve as models for studying both survival and increased virulence of hereditary and sporadic colorectal cancers."


'/>"/>

Contact: Kristine Crane
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. The Right Colorectal Cancer Test for the Right Patient
2. Life Line Screening Offers Special Pricing on Colorectal Home Test Kits in Honor of National Colorectal Cancer Month
3. A new indicator of poor prognosis in node-negative colorectal cancer patients
4. Physicians come together on National Colorectal Cancer Awareness and Screening Day
5. High weight associated with risk of colorectal tumors without microsatellite instability
6. New study implicates health care utilization, over biology, in colorectal cancer disparities
7. Leukemia-related protein 16 and colorectal carcinoma
8. Hispanics live in areas with limited capacity for colorectal cancer screening
9. UAB researchers find 4 biomarkers important in colorectal cancer treatment prognosis
10. Association of fiber and colorectal cancer risk differs depending on dietary assessment method
11. Researchers show that nitric oxide-donating naproxen can boost colorectal cancer prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , ... February 24, 2017 , ... ... into the Senior International Elite division on February 12th. Ms. Esparza qualified ... at the elite qualifier competition held in Las Vegas, Nevada. Frida is one ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an official 2017 partnership with The Jensie Gran Fondo of Marin. For the ... UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide ...
(Date:2/23/2017)... ... February 23, 2017 , ... The 89th Academy Awards will be celebrated this ... Education Policy Center Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek ... winner is the Center for American Progress (CAP), for its report, Lessons From State ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... clinician-based audience, will be participating in Rare Disease Day events, hosted by the ... addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will be ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, ... June: From Not to Hot,” which will begin airing on February 24, 2017. The ... millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017 ITL Limited, ( ASX: ITD ), ... for the half year ended 31 December 2016 compared with the ... presentation can be viewed here . Highlights ... $1.04m; up 104%) Earnings per share of 2.2 ... of $17.5m (Dec 2015: $15.7m; up 11%) Profit ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
(Date:2/23/2017)... , February 23, 2017 Obese ... increasing caseload for varicose veins in their body. The ... are prompting the adoption of endovenous laser therapy for ... endovenous laser therapy market, published by Future ... lifestyle choices and consequences of obesity have collectively factored ...
Breaking Medicine Technology: